Skip to content

To study the effect of Canaxon MR tablet in generalized muscular spasm.

A pilot exploratory clinical study to evaluate the efficacy of Canaxon MR tablets in the patients with mild to moderate generalized muscular spasm. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075125
Enrollment
30
Registered
2024-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M629- Disorder of muscle, unspecified

Interventions

None listed

Sponsors

Evmed solutions
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged between 18-65 year irrespective of gender Willingness to comply with study requirements and follow instructions. Patients having complaints of muscle spasm,pain and difficulty in movements due to muscle stiffness which are symptoms of osteoarthritis,sciatica,sports injury,ageing.

Exclusion criteria

Exclusion criteria: Individuals with known allergies to the disease specific that is having chronic and severe form of diseases. Pregnant or breastfeeding women. recent participation in another clinical trial current substance abuse or dependence.

Design outcomes

Primary

MeasureTime frame
To relieve spasm and pain.Timepoint: 14 days with 2 follow ups on 7th and 14th day.

Secondary

MeasureTime frame
To observe adverse effects if anyTimepoint: 14 days study with follow up on 7th and 14th day

Countries

India

Contacts

Public ContactDr.Apeksha Kulkarni

Dr.D Y Patil College of Ayurveda and Research Centre Pimpri Pune

apekshakulkarni473@gmail.com9112979323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026